News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BAKER BROS. ADVISORS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 2.2% stake in Mereo BioPharma Group plc |
| 08/10/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 0% stake in Verastem, Inc. |
| 06/12/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 8% stake in Verastem, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 2.3% stake in Surrozen, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 6.8% stake in Opthea Limited |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 13.5% stake in Verastem, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 5.9% stake in Zymeworks Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 9.1% stake in Cerus Corporation |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 0% stake in Merus N.V. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Mereo BioPharma Group plc |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 9.9% stake in Achilles Therapeutics plc |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 8.7% stake in Ascendis Pharma A/S |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 8% stake in Aerovate Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 6.8% stake in Immatics N.V. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 11.3% stake in Rhythm Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Nurix Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 9% stake in MADRIGAL PHARMACEUTICALS, INC. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/12/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/07/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10.9% stake in Rhythm Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 4.4% stake in Invitae Corporation |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 7.7% stake in Rhythm Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 13.8% stake in Otonomy, Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Zymeworks Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Mereo BioPharma Group plc |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 11.8% stake in Verastem, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 7.5% stake in Opthea Limited |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 8% stake in Heron Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 8% stake in Ascendis Pharma A/S |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 5.4% stake in Amarin Corporation plc |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|